Testing infrastructure
Identify the right laboratories and technologies for genomics, metabolomics, targeted assays, and biomarker measurement.
MOLECULAR DIAGNOSTICS • EUROPE
Molecular diagnostics,
built to scale.
Molecular diagnostics will not scale through science alone — scaling also requires the right operating infrastructure. Agile-BioSys connects laboratories, clinics, molecular platforms, biomarker expertise, and practical testing workflows across Europe.
European Molecular Network Building
WHAT WE DO
From molecular capability to deployable service.
We help clinics, laboratories, and diagnostic companies connect the scientific and operational pieces needed to launch and scale molecular testing.
Pipeline design
Build practical sample-to-result workflows covering collection, routing, QC, data formats, analysis, and reporting.
Clinical & scientific strategy
Translate biomarker evidence into focused test concepts, clinician-ready interpretation, and longitudinal monitoring.
Partnership & scale-up
Connect clinics, laboratories, technology companies, and commercial partners to support pilots and European expansion.
THE MODEL
Local access. European scale.
We build interoperable partner networks rather than forcing every project through one laboratory or one technology.
01Clinic / CompanyDefines the use case
→
02Lab / PlatformBest-fit molecular technology
→
03InterpretationClinical and scientific context
→
04Scalable ServiceReady for deployment
GenomicsSNP arrays • sequencing • PRS
MetabolomicsNMR • LC-MS • metabolic profiling
CardiometabolicApoB • ApoA1 • Lp(a) • biomarkers
DataQC • interpretation • longitudinal reporting
WHO WE WORK WITH
Built around partnership.
We help each partner contribute what they do best, while reducing the friction between technology, testing, interpretation, and clinical delivery.
Add advanced testing without building the infrastructure.
Testing pathways, laboratory access, interpretation concepts, white-label services, and pilot support.
Turn analytical capability into a clearer clinical product.
Clinical positioning, biomarker strategy, distribution partnerships, and new B2B use cases.
Find the right route into European clinical markets.
Use-case design, pilot partners, commercialization strategy, and network development.
ABOUT AGILE-BIOSYS
Science-led. Operationally focused.
Agile-BioSys is a growing network of researchers and collaborators with experience in molecular physiology, cardiovascular and metabolic biomarkers, bioinformatics, multi-omics, genetics, and human health research.
Our initial scientific focus is cardiometabolic health, with broader interest in molecular technologies that improve risk stratification, monitoring, and preventive care.
PARTNERSHIPS
Let’s build the right diagnostic pathway.
We are speaking with clinics, diagnostic companies, molecular laboratories, metabolomics and genomics platforms, and health-technology partners across Europe.
Diagnostic partnershipsClinic pilotsLaboratory networkTechnology collaborations